Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2015 Nov-Dec;21(6):339–342. doi: 10.1097/SPV.0000000000000189

The Differential Impact of Flatal Incontinence in Women With Anal Versus Fecal Incontinence

Isuzu Meyer 1, Ying Tang 2, Jeff M Szychowski 3, Holly E Richter 4
PMCID: PMC4624252  NIHMSID: NIHMS673269  PMID: 26506162

Abstract

Objectives

The differential impact on quality of life (QOL) that leakage of both stool and flatus confers on women compared to stool only is unclear. Our aim was to characterize differences in symptom distress, impact on QOL, and anorectal testing among women with leakage of stool and flatus, stool only, and flatus only.

Methods

A retrospective review was conducted of women undergoing evaluation of at least monthly bowel incontinence symptoms. Subjects were divided into 3 groups: liquid/solid stool and flatus (anal incontinence, AI); liquid/solid stool only (fecal incontinence, FI); and flatal only (FL). Baseline assessment included the Modified Manchester Health Questionnaire (MMHQ) including the Fecal Incontinence Severity Index (FISI), Short Form-12 (SF-12), as well as anorectal manometry and endoanal ultrasound evaluations.

Results

Of 436 subjects, 381 had AI, 45 FI, and 10 FL. Significant between-group differences were noted in MMHQ (p=0.0002) and FISI total scores (p<0.0001) where women with AI reflected greater negative impact than women with FI. The SF-12 (PCS, MCS) scores were similar in all three groups (p=0.22, 0.08). Resting/squeeze pressures were significantly lower in AI and FI groups compared to FL (p=0.0004), whereas rectal capacity was similar in all three groups. Although exploratory, MMHQ scores were similar between FI and FL groups, although FISI scores were higher in the FI group (p<0.0001).

Conclusions

Women with AI have higher symptom specific distress and greater negative impact on QOL compared to women with FI. Treatment of all bowel incontinence symptoms is important to improve symptom-specific and general QOL.

Keywords: Anal incontinence, Fecal incontinence, Accidental bowel leakage, Flatal incontinence, Quality of life

Introduction

Anal incontinence (AI), defined as the involuntary leakage of gas, mucous, liquid, and/or solid stool, is a physically and psychologically devastating condition which negatively impacts quality of life (QOL).1,2 Fecal incontinence (FI) is defined as leakage of either liquid or solid stool only (without flatus).3-10 A recent study reported that the most women prefer the term accidental bowel leakage (ABL) to describe these conditions.11,12 The prevalence of anal or fecal incontinence varies widely from 2 to 24 % of the US population, depending on the population being queried and the definition of the condition.3,4,7,9,13-16 Despite its severe impact on both patients and society, the majority of women with anal or fecal incontinence do not seek care.9,17 While studies have demonstrated the etiology, impact, and risk factors of AI, such as age, parity, obesity, mode of delivery, impaired mobility, comorbid diseases, and stool consistency,10,13,18-20 most existing studies focus solely on FI only.

The most common type of bowel leakage is thought to be flatal incontinence only (FL), and its prevalence has been reported substantially higher than stool leakage.3,9,19,21 According to previous investigations, whether leakage of gas has less impact on QOL is controversial9,21,22 and limited data exist on this issue.21,22 Thus, the differential impact on QOL that flatal incontinence confers in women with AI compared to women with leakage of stool only remains unclear.

The primary aim of this study was to characterize differences in symptom distress, impact on QOL, and baseline anorectal diagnostic testing findings between women with AI to women with FI. As an exploratory aim, we also compared characteristics of women with flatal incontinence only to those with FI.

Materials and Methods

Women undergoing evaluation of AI, FI and FL between 2003 and 2013 Genito-Rectal Disorders Clinic at the University of Alabama at Birmingham were eligible for this retrospective cohort study. This study received IRB approval, and all participants provided written informed consent. Demographic and medical history data were collected on each patient including: age, race, smoking behavior, hypertension, pulmonary disease, diabetes, prior colorectal surgery, hysterectomy, and history of sphincter disruption. Participants completed validated questionnaires rating symptom specific distress, impact and general QOL measures, including the Modified Manchester Questionnaire (MMHQ, range 0-100) which includes the Fecal Incontinence Severity Index (FISI, range 0-61), and the Short Form-12 (SF-12, range 0-100) including the mental and physical component summary scores (MCS and PCS), respectively.1,23,24 Participants were included in the study if they had evidence of bowel incontinence demonstrated by a positive response to leakage of gas, liquid or solid stool at least once a month using the MMHQ. The subjects were divided into three groups; the AI group comprised women with liquid/solid stool and flatal incontinence, the FI group comprised women with liquid/solid stool incontinence (no flatal incontinence), and the FL group of women with flatal incontinence only. All participants underwent baseline anorectal manometry (ARM) measures (resting sphincter tone, sphincter squeeze pressure, and rectal capacity) and endoanal ultrasonography characterizing whether the external and internal sphincters were intact.

The primary aim was to characterize differences in clinical and demographic characteristics as well as symptom distress and impact on QOL in women with AI compared to women with FI. A global comparative analysis across the 3 groups was also performed. Comparisons involving women with only flatal incontinence were also of interest, but were limited by a small sample size. Thus, analyses involving the flatal only group were investigated as exploratory only.

For comparisons of patient characteristics and questionnaire outcomes among groups, chi-square and Fisher’s exact tests were used for categorical measures, as appropriate. Two sample t-tests and Wilcoxon rank-sum tests were used for continuous measures. For comparisons across all 3 study groups, chi-square tests of association were used for categorical measures and one-way analysis of variance (ANOVA) were used for continuous measures. When distributional assumptions for these methods were not met, Pearson exact tests and Kruskal-Wallis tests were used. Statistical significance was evaluated at ≤ 0.001 to account for multiple comparisons. Statistical analyses were conducted using SAS version 9.3 (SAS Institute, Inc., Cary, NC).

Results

Four hundred thirty-six eligible subjects were included in the analysis: 381 subjects with AI, 45 with FI, and 10 FL. Overall, participants were predominantly White (87%) and had a mean age of 57 ± 14 years. The clinical and demographic characteristics were similar among all 3 groups (Table 1).

Table 1.

Patient Demographics

Groups Overall
(N=436)
AI#
(N=381)
FI#
(N=45)
FL#
(N=10)
P
(global)
P
(AI vs FI)
P
(FI vs FL)
Characteristics
Age (years), mean ± SD 57 ± 14 57 ± 13 61 ± 16 46 ± 17 0.005 0.05 0.001
White Race, n (%) 378 (87%) 332 (87%) 36 (80%) 10 (100%) 0.19 0.19 0.19*
**BMI, n (%) 0.07* 0.42 0.04*
 Underweight 11 (3%) 8 (2%) 2 (4%) 1 (10%)
 Normal 127 (29%) 111 (29%) 15 (33%) 1 (10%)
 Overweight 135 (31%) 118 (31%) 16 (36%) 1 (10%)
 Obese 163 (37%) 144 (38%) 12 (27%) 7 (70%)
Smoker, n (%) 63 (14%) 58 (15%) 4 (9%) 1 (10%) 0.48 0.25 >0.99*
Prior Colorectal Surgery,
n (%)
52 (12%) 49 (13%) 3 (7%) 0 (0%) 0.24 0.23 >0.99*
Hysterectomy, n (%) 307 (70%) 272 (71%) 31 (69%) 4 (40%) 0.10 0.73 0.14*
Sphincter disruption,
n (%)
136 (31%) 121 (32%) 12 (27%) 3 (30%) 0.78 0.49 >0.99*
*

Exact test

#

AI, anal incontinence; FI, fecal incontinence; FL, flatal incontinence

**

Underweight; < 18.5kg/m2, Normal; ≥ 18.5 and < 25 kg/m2, Overweight; ≥ 25 and 30 kg/m2, Obese; ≥ 30 kg/m2

When comparing bowel symptoms in the AI to the FI group, there were significant differences noted in symptom-specific distress and impact with respect to baseline MMHQ total scores (p = 0.0002), the role limitation subscale of MMHQ (p = 0.0007) and FISI scores (p < 0.0001), women having AI being more impacted (Table 2). The PCS subscale score of the SF-12 did not differ between the 2 groups (p = 0.27), whereas the MCS subscale score trended lower in women with AI (p = 0.03), though not statistically significant at the 0.001 level.

Table 2.

Bowel Symptom Distress and Impact

Overall
(N=436)
AI
(N=381)
FI
(N=45)
FL
(N=10)
P
(global)
P
(AI vs FI)
P
(FI vs FL)
Total MMHQ,
mean ± SD
51.3 ± 20.8 52.8 ± 20.4 40.9 ± 21.4 39.8 ± 19.4 0.0002 0.0002 0.89
Subscales of MMHQ
1. Impact 57.1 ± 23.5 58.3 ± 22.7 48.9 ± 27.2 47.5 ± 27.5 0.02 0.01 0.86
2. Role 49.8 ± 28.5 51.9 ± 27.5 36.9 ± 30.3 26.3 ± 32.5 <0.0001 0.0007 0.27
3. Physical 51.9 ± 28.8 53.5 ± 27.8 40.8 ± 33.4 38.8 ± 34.6 0.007 0.005 0.83
4. Social 43.3 ± 32.8 44.8 ± 32.6 32.8 ± 33.4 31.3 ± 27.8 0.03 0.02 0.89
5. Relationship 42.4 ± 33.2 44.2 ± 33.1 27.8 ± 31.6 40.0 ± 29.3 0.007 0.002 0.29
6. Emotion 59.8 ± 26.1 61.2 ± 25.1 50.0 ± 32.0 50.0 ± 25.1 0.01 0.007 >0.99
7. Sleep/Energy 38.0 ± 32.0 39.5 ± 32.0 26.9 ± 29.8 32.5 ± 35.5 0.04 0.01 0.62
8. Severity 68.2 ± 20.2 69.2 ± 19.4 62.8 ± 22.1 52.5 ± 32.5 0.04* 0.04** 0.23**
FISI 28.8 ± 12.5 31.0 ± 11.5 15.4 ± 6.8 5.4 ± 2.7 <0.0001* <0.0001** <.0001^
SF-12 Subscale
Score, mean ± SD
PCS 41.5 ± 11.7 41.2 ± 11.7 43.3 ± 12.4 46.4 ± 11.1 0.22 0.27 0.45
MCS 41.6 ± 12.3 41.2 ± 12.4 45.7 ± 12.3 40.9 ± 8.7 0.08 0.03 0.26
*

Kruskal-Wallis

**

two sample t-test

^

Wilcoxon rank-sum test

Despite the limited sample size, we characterized differences in women with FI to those with flatal incontinence only as an exploratory aim. Women with flatal incontinence only were significantly younger (mean 46 vs. 61, p = 0.001). Although the FISI total score was higher in women with FI (p < 0.0001), there were no differences in either the total or the individual subscale scores of the MMHQ between women with FI and those with flatal incontinence only. The SF-12 (PCS and MCS) scores were also similar between the FI only and flatal only groups (p = 0.45, 0.26, respectively).

Women with AI and FI had significantly lower resting and squeeze pressures (global p = 0.0004 and 0.001, respectively) compared to those with FL, whereas rectal capacity was similar in all three groups (global p = 0.54, Table 3). There were no differences in the rates of external and internal sphincter defects (global p = 0.05 and 0.39, respectively).

Table 3.

Anorectal Diagnostic Test Results

Overall
(N=436)
AI
(N=381)
FI
(N=45)
FL
(N=10)
P
(global)
P
(AI vs FI)
P
(FI vs FL)
Anorectal manometry, mean (std)
Resting Pressure mmHg 35.8 (19.2) 35.0 (18.6) 37.9 (16.3) 58.5 (35.7) 0.0004 0.33 0.002
Squeeze Pressure, mmHg 73.1 (36.0) 71.5 (35.0) 78.5 (32.1) 111.7 (61.1) 0.001 0.21 0.008
Rectal Capacity, mL 117.0 (55.4) 117.5 (55.7) 110.2 (56.2) 130.0 (38.4) 0.54 0.41 0.31
Endoanal ultrasonography, n (%)
EAS defect 97 (22%) 86 (23%) 11 (24%) 0 (0%) 0.05* 0.41 0.009*
IAS defect 64 (15%) 58 (15%) 6 (13%) 0 (0%) 0.39 0.74 0.58
*

Exact test

Discussion

Anal incontinence is a physically and psychosocially debilitating condition. In this study, women with AI have greater symptom specific distress as well as greater negative impact on QOL compared to women with FI as measured by the FISI and MMHQ. These findings bring up an interesting insight that having flatal leakage can add a significant impact to QOL to the already bothersome FI.

In comparison, findings noted comparing women with FI and flatus only as an exploratory aim revealed no difference in the disease specific QOL measures (MMHQ total and all subscales), although the incontinence severity score was lower in women with flatal incontinence only. Although exploratory, this suggests that the burden of flatal incontinence carries similar weight to that of stool leakage. This finding is consistent with existing data that women’s QOL is still highly affected by their bowel symptoms even when their incontinence severity index scores may be lower.31

The SF-12 was designed to measure general health status with a high score indicating better physical functioning with a mean of 50 and a standard deviation (SD) of 10 in a representative sample of the US population.32,33 Our study demonstrated that women with bowel incontinence, regardless of the type of leakage, scored lower than 50 on both PCS and MCS. Although not statistically significant at a 0.001 level of significance, the mean MCS score was lower in the AI group compared to the FI group (41.2 ± 12.4 vs. 45.7 ± 12.3, p = 0.03, Table 2). The addition of flatus to leakage of stool not only adds a disease-specific negative psychological burden, but could also have overall mental impact to patients’ general well-being. It is important for healthcare providers to approach those who suffer from AI as an opportunity for disease management leading toward better health.

The prevalence of combined flatal/fecal incontinence (87%) was much higher than either solely fecal (10%) or flatal (2.3%) incontinence in this single site study. The prevalence of flatal incontinence only reported by other existing studies of community dwelling women or other study populations has been reported to be as high as 49%, mostly in populations not actively seeking care for this condition.9,21,22 The low rate of flatal incontinence only in this current population may be explained by several factors. First, the definition of flatal incontinence varies among existing studies. Some studies have used the question from the Pelvic Floor Distress Inventory (PFDI-20), “do you usually lose gas from the rectum beyond your control?” to determine the presence of flatal incontinence.21,22 In those studies, it is unclear whether women with concurrent stool leakage were excluded in their data analysis, as this may have inflated their reported prevalence of “flatal” only incontinence. In comparison, our study demonstrated the prevalence of solely flatal incontinence in a population of women seeking care for their condition. Moreover, the population analyzed in other studies included patients who presented to either gynecology or urogynecology clinics for various complaints, whereas the subjects in this current study were those typically referred from their primary care physicians or gynecologists to the urogynecology clinic specifically for evaluation of FI, AI or flatal incontinence. Populations studied in urogynecology clinics, in general, have been reported to have higher prevalence rates of FI and AI.10,25 The prevalence rate observed from the population in this study may differ from community-based samples. However, interestingly, this study suggests that more women with stool leakage seek medical care compared to those with flatal incontinence only, even though the impact of flatal incontinence only and FI on QOL was noted to be similar in this study.

Limited data suggest that flatal incontinence is more common among people with internal anal sphincter defects after undergoing lateral internal sphincterotomy for chronic anal fissure.26-30 However, anatomical or functional changes of the anorectum related to flatus have not been well documented. In this study, diagnostic testing with anal manometry showed that women with AI had the lowest baseline anal resting tone and squeeze pressures when comparing all three groups, however, no differences were noted with regard to external and internal sphincter defects among the 3 groups (global p = 0.05, 0.39, respectively). Further research is needed to explore other risk factors leading to flatal incontinence, in general.

This study is limited by a small sample size of women with flatal incontinence only. However, the disproportionate distribution of fecal vs. flatal incontinence may be an accurate representation of women who seek care for bowel leakage presenting to a specialty clinic.

Strengths of this study include that overall this is a large population of well characterized women presenting with at least monthly bowel leakage symptoms characterized using validated measures. This study differs from existing studies, which reflect data from subjective measures only, as we also characterized differences in objective measures using anorectal manometry and endoanal ultrasonography to assess a broader perspective of fecal and flatal incontinence in women. In addition, we robustly compared populations accounting for multiple comparisons.

In conclusion, women with AI are more significantly impacted than those with FI. Despite a limited sample size, the impact of flatal incontinence only in women appears to have both physical and psychological burdens similar to that of women with FI, but further research is needed in women presenting for care with only flatal incontinence. The findings from this study add to the limited, yet growing literature on the differential impact of bowel incontinence, especially flatal incontinence, upon QOL. All individuals presenting with bowel incontinence should be specifically asked about flatal incontinence. More research in a larger sample of women with these conditions is needed to more fully understand the pathophysiology of AI and flatal incontinence alone so treatment approaches can be optimized.

Acknowledgments

Grant Support: Partially supported by the National Institutes of Diabetes and Digestive and Kidney Diseases, 2K24-DK068389 to HE Richter. For the remaining authors, none were declared.

Footnotes

Disclosures: None

Conflict of interest: None

Contributor Information

Isuzu Meyer, Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama

Ying Tang, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama

Jeff M Szychowski, Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama

Holly E Richter, Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama

REFERENCES

  • 1.Ellington DR, Polin MR, Szychowski JM, et al. The effect of obesity on fecal incontinence symptom distress, quality of life and diagnostic testing measures in women. Int Urogynecol J. 2013;24(10):1733–38. doi: 10.1007/s00192-013-2103-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Norton C, Whitehead W, Bliss DZ, et al. Incontinence. Health Publication Ltd; Paris, France: 2009. Conservative and pharmacological management of faecal incontinence in adults; p. 1343. [Google Scholar]
  • 3.Nelson R, Norton N, Cautley E, Furner S. Community-based prevalence of anal incontinence. JAMA. 1995;274(7):559–61. [PubMed] [Google Scholar]
  • 4.Rothbarth J, Bemelman WA, Meijerink WJ, et al. What is the impact of fecal incontinence on quality of life? Dis Colon Rectum. 2001;44:67. doi: 10.1007/BF02234823. [DOI] [PubMed] [Google Scholar]
  • 5.Landefeld CS, Bowers BJ, Feld AD, et al. National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med. 2008;148:449–58. doi: 10.7326/0003-4819-148-6-200803180-00210. [DOI] [PubMed] [Google Scholar]
  • 6.Wald A. Fecal incontinence in adults. Wald A. N Engl J Med. 2007;367:1648–55. doi: 10.1056/NEJMcp067041. [DOI] [PubMed] [Google Scholar]
  • 7.Markland AD, Kraus SR, Richter HE, Nager CW, Kenton K, Kerr L, Xu Y. Prevalence and risk factors of fecal incontinence in women undergoing stress incontinence surgery. Am J Obstet Gynecol. 2007;197:662.e1–662e7. doi: 10.1016/j.ajog.2007.08.062. [DOI] [PubMed] [Google Scholar]
  • 8.Markland AD, Richter HE, Burgio KL, Bragg C, Hernandez AL, Subak LL. Fecal incontinence in obese women with urinary incontinence: prevalence and role of dietary fiber intake. Am J Obstet Gynecol. 2009 Jan;200(5):566e1–566e8. doi: 10.1016/j.ajog.2008.11.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Boreham MK, Richter HE, Kenton KS, Nager CW, et al. Anal incontinence in women presenting for gynecologic care: Prevalence, risk factors, and impact upon quality of life. Am J Obstet Gynecol. 2005;192:1637–42. doi: 10.1016/j.ajog.2004.11.030. [DOI] [PubMed] [Google Scholar]
  • 10.Varma MG, Brown JS, et al. Fecal incontinence in females older than aged 40 years: Who is at risk? Dis Colon Rectum. 2006;49(6):841–51. doi: 10.1007/s10350-006-0535-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Brown HW, Wexner SD, Segall MM, et al. Accidental bowel leakage in the mature women’s health study: prevalence and predictors. Int J Clin Pract. 2012;66(11):1101–08. doi: 10.1111/ijcp.12018. [DOI] [PubMed] [Google Scholar]
  • 12.Brown HW, Wexner SD, Segall MM, et al. Quality of life impact in women with accidental bowel leakage. Int J. Clin Pract. 2012;66(11):1109–16. doi: 10.1111/ijcp.12017. [DOI] [PubMed] [Google Scholar]
  • 13.Markland AD, Richter HE, Burgio KL, Myers DL, Hernandez AL, Subak LL. Weight loss improves fecal incontinence severity in overweight and obese women with urinary incontinence. Int Urogynecol J. 2011 Sep;22(9):1151–7. doi: 10.1007/s00192-011-1444-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300:1311–1316. doi: 10.1001/jama.300.11.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gleason JL, Markland AD, Greer WJ, Szychowski JM, Gerten KA, Richter HE. Anal sphincter repair for fecal incontinence: effect on symptom severity, quality of life, and anal sphincter squeeze pressures. Int Urogynecol J. 2011 Dec;22(12):1587–92. doi: 10.1007/s00192-011-1551-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cockell SJ, Oates-Johnson T, Gilmour DT, et al. Postpartum flatal and fecal incontinence quality-of-life scale: A disease and population specific measure. Qual Health Res. 2003;13:1132–44. doi: 10.1177/1049732303256410. [DOI] [PubMed] [Google Scholar]
  • 17.Gordon D, Groutz A, Goldman G, Avini A, et al. Anal incontinence: Prevalence among female patients attending a urogynecologic clinic. Neurourol Urodyn. 1999;18:199–204. doi: 10.1002/(sici)1520-6777(1999)18:3<199::aid-nau6>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  • 18.Melville JL, Fan MY, Newton K, Fenner D. Fecal incontinence in US women: a population-based study. Am J Obstet Gynecol. 2005;193:2071–2076. doi: 10.1016/j.ajog.2005.07.018. [DOI] [PubMed] [Google Scholar]
  • 19.Goode PS, Burgio KL, Halli AD, et al. Prevalence and correlates of fecal incontinence in community-dwelling older adults. J Am Geriatr Soc. 2005;53:629–635. doi: 10.1111/j.1532-5415.2005.53211.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 20.Quander CR, Morris MC, Melson J, Bienias JL, Evans DA. Prevalence of and factors associated with fecal incontinence in a large community study of older individuals. Am J Gastroenterol. 2005;100:905–909. doi: 10.1111/j.1572-0241.2005.30511.x. [DOI] [PubMed] [Google Scholar]
  • 21.Steinberg AC, Collins SA, O’Sullivan DM. The impact of flatal incontinence on quality of life. Am J Obstet Gynecol. 2009;201:539.e1–3. doi: 10.1016/j.ajog.2009.07.050. [DOI] [PubMed] [Google Scholar]
  • 22.Collins SA, Martin M, O’Sullivan DM, et al. Effect of flatal incontinence on sexual function. Female Pelvic Med Reconstr Surg. 2011;17:70–3. doi: 10.1097/SPV.0b013e31820a5334. [DOI] [PubMed] [Google Scholar]
  • 23.Kwon S, Visco AG, Fitzgerald MP, et al. Pelvic Floor Disorders Network (PFDN) Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence. Dis Colon Rectum. 2005;48(2):323–31. doi: 10.1007/s10350-004-0899-y. 331-4. [DOI] [PubMed] [Google Scholar]
  • 24.Luo X, Lynn GM, Kakouras I, et al. Reliability, validity, and responsiveness of the short form 12-item survey (SF-12) in patients with back pain. Spine. 2003;28:1739–45. doi: 10.1097/01.BRS.0000083169.58671.96. [DOI] [PubMed] [Google Scholar]
  • 25.Bharucha AE, Zinsmeister AR, Locke GR, et al. Prevalence and burden of fecal incontinence: a population based study in women. Gasteroenterol. 2005;129:42–9. doi: 10.1053/j.gastro.2005.04.006. [DOI] [PubMed] [Google Scholar]
  • 26.Costilla VC, Foxx-Orenstein AE, Crowell MD, et al. Office-based management of fecal incontinence. Gastroenterol Hepatol. 2013;9(7):423–33. [PMC free article] [PubMed] [Google Scholar]
  • 27.Nelwon RL, Chartopadhyay A, Brooks W, et al. Operative procedures for fissure in ano. Cochrane Database Syst Rev. 2011;11 doi: 10.1002/14651858.CD002199.pub4. CD002199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mentes BB, Tezcaner T, Yilmaz U, et al. Results of lateral internal sphincterotomy for chronic anal fissure with particular reference to quality of life. Dis Colon Rectum. 2006;49:1045–51. doi: 10.1007/s10350-006-0527-0. [DOI] [PubMed] [Google Scholar]
  • 29.Murad-Regadas SM, da Silva Fernandes GO, Regadas FSP, et al. How much of the internal sphincter may be divided during lateral sphincterotomy for chronic anal fissure in women? Morphologic and functional evaluation after sphincterotomy. Dis Colon Rectum. 2013;56(5):645–51. doi: 10.1097/DCR.0b013e31827a7416. [DOI] [PubMed] [Google Scholar]
  • 30.Nyam D, Pemberton J. Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum. 1999;42(10):1306–10. doi: 10.1007/BF02234220. [DOI] [PubMed] [Google Scholar]
  • 31.Bordeianou L, Rockwood T, Baxter N, et al. Does incontinence severity correlate with quality of life? Prospective analysis of 502 consecutive patients. Colorectal Disease. 2007;10:273–9. doi: 10.1111/j.1463-1318.2007.01288.x. [DOI] [PubMed] [Google Scholar]
  • 32.The US Bureau of Labor Statistics. National Longitudinal Surveys NLSY79: SF-12 Health Scale Scoring. Retrieved June 5, 2014, https://www.nlsinfo.org.
  • 33.SF-12, ALSFRS Interpretation guides to standardized questionnaires. The ALS C.A.R.E. Program. Retrieved June 5, 2014. http://www.outcomes-umassmed.org/ALS/sf12.aspx.

RESOURCES